Immunotherapy biomarkers: the long and winding road
Nat Rev Clin Oncol
.
2021 Jun;18(6):323-324.
doi: 10.1038/s41571-021-00498-w.
Authors
Tyler J Alban
1
2
,
Timothy A Chan
3
4
5
6
Affiliations
1
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA.
2
Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
3
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, OH, USA. chant2@ccf.org.
4
Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. chant2@ccf.org.
5
Case Comprehensive Cancer Center, Cleveland, OH, USA. chant2@ccf.org.
6
Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA. chant2@ccf.org.
PMID:
33727676
DOI:
10.1038/s41571-021-00498-w
No abstract available
Publication types
Research Support, N.I.H., Extramural
Comment
MeSH terms
Biomarkers
Humans
Immunologic Factors*
Immunotherapy*
Substances
Biomarkers
Immunologic Factors
Grants and funding
R01 CA205426/CA/NCI NIH HHS/United States
R35 CA232097/CA/NCI NIH HHS/United States